Trial Profile
A Multi-Center, Double-Blind, Randomized, Superiority Clinical Study to Compare the Effects of Cilnidipine on Metabolic Syndrome Improvement With Nifedipine GITS in Hypertensive Patients With Metabolic Syndrome (Phase IV) [SLIMS]
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Jul 2022
Price :
$35
*
At a glance
- Drugs Cilnidipine (Primary) ; Nifedipine
- Indications Essential hypertension
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms SLIMS
- Sponsors Boryung Pharmaceutical
- 16 Apr 2011 New trial record